An update on male breast cancer and future directions for research and treatment
© 2013 Elsevier B.V. All rights reserved..
Male breast cancer is a rare disease for which treatment has been based on the evidence available from female breast cancer. The new genomic tools can better characterize the biology of breast cancer. It is hoping that these will help to clarify possible differences of breast cancer behaviour in male patients, which will have a major impact on treatment strategies and on the conduct of clinical trials in this setting. In this review we will summarize available information on epidemiology, risk factors for breast cancer in men, the new insights of the biology of this disease, current recommendations for treatment and insights for future research.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:717 |
|---|---|
| Enthalten in: |
European journal of pharmacology - 717(2013), 1-3 vom: 05. Okt., Seite 71-83 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sousa, Berta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarker |
|---|
| Anmerkungen: |
Date Completed 23.06.2014 Date Revised 19.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejphar.2013.03.037 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM226287858 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM226287858 | ||
| 003 | DE-627 | ||
| 005 | 20231224071110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejphar.2013.03.037 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0754.xml |
| 035 | |a (DE-627)NLM226287858 | ||
| 035 | |a (NLM)23545364 | ||
| 035 | |a (PII)S0014-2999(13)00254-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sousa, Berta |e verfasserin |4 aut | |
| 245 | 1 | 3 | |a An update on male breast cancer and future directions for research and treatment |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.06.2014 | ||
| 500 | |a Date Revised 19.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2013 Elsevier B.V. All rights reserved. | ||
| 520 | |a Male breast cancer is a rare disease for which treatment has been based on the evidence available from female breast cancer. The new genomic tools can better characterize the biology of breast cancer. It is hoping that these will help to clarify possible differences of breast cancer behaviour in male patients, which will have a major impact on treatment strategies and on the conduct of clinical trials in this setting. In this review we will summarize available information on epidemiology, risk factors for breast cancer in men, the new insights of the biology of this disease, current recommendations for treatment and insights for future research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biomarker | |
| 650 | 4 | |a Chemotherapy | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Hormonal therapy | |
| 650 | 4 | |a Male breast cancer | |
| 700 | 1 | |a Moser, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Cardoso, Fatima |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of pharmacology |d 1967 |g 717(2013), 1-3 vom: 05. Okt., Seite 71-83 |w (DE-627)NLM000029769 |x 1879-0712 |7 nnns |
| 773 | 1 | 8 | |g volume:717 |g year:2013 |g number:1-3 |g day:05 |g month:10 |g pages:71-83 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejphar.2013.03.037 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 717 |j 2013 |e 1-3 |b 05 |c 10 |h 71-83 | ||